http://purl.org/np/RAM3tR4QETEN38seVBCONFMMKbwMpmCou8X5dhed_bjzs#Head http://purl.org/np/RAM3tR4QETEN38seVBCONFMMKbwMpmCou8X5dhed_bjzs http://www.nanopub.org/nschema#hasAssertion http://purl.org/np/RAM3tR4QETEN38seVBCONFMMKbwMpmCou8X5dhed_bjzs#assertion http://purl.org/np/RAM3tR4QETEN38seVBCONFMMKbwMpmCou8X5dhed_bjzs http://www.nanopub.org/nschema#hasProvenance http://purl.org/np/RAM3tR4QETEN38seVBCONFMMKbwMpmCou8X5dhed_bjzs#provenance http://purl.org/np/RAM3tR4QETEN38seVBCONFMMKbwMpmCou8X5dhed_bjzs http://www.nanopub.org/nschema#hasPublicationInfo http://purl.org/np/RAM3tR4QETEN38seVBCONFMMKbwMpmCou8X5dhed_bjzs#pubinfo http://purl.org/np/RAM3tR4QETEN38seVBCONFMMKbwMpmCou8X5dhed_bjzs http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.nanopub.org/nschema#Nanopublication http://purl.org/np/RAM3tR4QETEN38seVBCONFMMKbwMpmCou8X5dhed_bjzs#assertion http://purl.obolibrary.org/obo/DOID_9351 https://w3id.org/biolink/vocab/category https://w3id.org/biolink/vocab/Disease http://purl.org/np/RAM3tR4QETEN38seVBCONFMMKbwMpmCou8X5dhed_bjzs#association http://www.w3.org/1999/02/22-rdf-syntax-ns#object http://purl.obolibrary.org/obo/DOID_9351 http://purl.org/np/RAM3tR4QETEN38seVBCONFMMKbwMpmCou8X5dhed_bjzs#association http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate https://w3id.org/biolink/vocab/treats http://purl.org/np/RAM3tR4QETEN38seVBCONFMMKbwMpmCou8X5dhed_bjzs#association http://www.w3.org/1999/02/22-rdf-syntax-ns#subject https://identifiers.org/drugbank:DB01306 http://purl.org/np/RAM3tR4QETEN38seVBCONFMMKbwMpmCou8X5dhed_bjzs#association http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.w3.org/1999/02/22-rdf-syntax-ns#Statement http://purl.org/np/RAM3tR4QETEN38seVBCONFMMKbwMpmCou8X5dhed_bjzs#association http://www.w3.org/2000/01/rdf-schema#label novolog mix 7 3 is an insulin analog indicated to improve glycemic control in patients with diabetes mellitus important limitations of use in premix insulins such as novolog mix 7 3 the proportions of rapid acting and long acting insulins are fixed and do not allow for basal versus prandial dose adjustments novolog mix 7 3 is an insulin analog indicated to improve glycemic control in patients with diabetes mellitus important limitations of use in premix insulins such as novolog mix 7 3 the proportions of rapid acting and long acting insulins are fixed and do not allow for basal versus prandial dose adjustments 1 http://purl.org/np/RAM3tR4QETEN38seVBCONFMMKbwMpmCou8X5dhed_bjzs#association https://w3id.org/biolink/vocab/association_type https://w3id.org/biolink/vocab/ChemicalToDiseaseOrPhenotypicFeatureAssociation http://purl.org/np/RAM3tR4QETEN38seVBCONFMMKbwMpmCou8X5dhed_bjzs#association https://w3id.org/biolink/vocab/provided_by https://w3id.org/um/NeuroDKG http://purl.org/np/RAM3tR4QETEN38seVBCONFMMKbwMpmCou8X5dhed_bjzs#association https://w3id.org/biolink/vocab/relation https://schema.org/TreatmentIndication https://identifiers.org/drugbank:DB01306 https://w3id.org/biolink/vocab/category https://w3id.org/biolink/vocab/Drug http://purl.org/np/RAM3tR4QETEN38seVBCONFMMKbwMpmCou8X5dhed_bjzs#provenance http://purl.org/np/RAM3tR4QETEN38seVBCONFMMKbwMpmCou8X5dhed_bjzs#assertion http://www.w3.org/ns/prov#wasAttributedTo https://orcid.org/0000-0002-1468-3557 http://purl.org/np/RAM3tR4QETEN38seVBCONFMMKbwMpmCou8X5dhed_bjzs#pubinfo http://purl.org/np/RAM3tR4QETEN38seVBCONFMMKbwMpmCou8X5dhed_bjzs#sig http://purl.org/nanopub/x/hasAlgorithm RSA http://purl.org/np/RAM3tR4QETEN38seVBCONFMMKbwMpmCou8X5dhed_bjzs#sig http://purl.org/nanopub/x/hasPublicKey MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB http://purl.org/np/RAM3tR4QETEN38seVBCONFMMKbwMpmCou8X5dhed_bjzs#sig http://purl.org/nanopub/x/hasSignature NhlSxi68i6MCQcK72x4La4U4ksTeHO0OnaSsmvDxrpL8kxVUdoGQ2k79mVDyS4wsw+VCSZBjc1pLqm96ZkSriBvGDxKSpQJX+QCZS6+D/tZ/nAFkHVcKLm4Pgt2eaCkoizFV4NqQ0w3PVEqxBsGQXlF6LXAoRUdyrbkcZy6WV2s= http://purl.org/np/RAM3tR4QETEN38seVBCONFMMKbwMpmCou8X5dhed_bjzs#sig http://purl.org/nanopub/x/hasSignatureTarget http://purl.org/np/RAM3tR4QETEN38seVBCONFMMKbwMpmCou8X5dhed_bjzs http://purl.org/np/RAM3tR4QETEN38seVBCONFMMKbwMpmCou8X5dhed_bjzs http://purl.org/dc/terms/created 2021-07-03T15:25:09.917+02:00 http://purl.org/np/RAM3tR4QETEN38seVBCONFMMKbwMpmCou8X5dhed_bjzs http://purl.org/dc/terms/creator https://orcid.org/0000-0002-1468-3557 http://purl.org/np/RAM3tR4QETEN38seVBCONFMMKbwMpmCou8X5dhed_bjzs https://w3id.org/np/o/ntemplate/wasCreatedFromProvenanceTemplate http://purl.org/np/RANwQa4ICWS5SOjw7gp99nBpXBasapwtZF1fIM3H2gYTM http://purl.org/np/RAM3tR4QETEN38seVBCONFMMKbwMpmCou8X5dhed_bjzs https://w3id.org/np/o/ntemplate/wasCreatedFromPubinfoTemplate http://purl.org/np/RAA2MfqdBCzmz9yVWjKLXNbyfBNcwsMmOqcNUxkk1maIM http://purl.org/np/RAM3tR4QETEN38seVBCONFMMKbwMpmCou8X5dhed_bjzs https://w3id.org/np/o/ntemplate/wasCreatedFromTemplate http://purl.org/np/RAManV5GZI01JKzW_IPcfOXoiFTcZMmsV7qTCLkdzr4Gs